Drugmaker Intra-Cellular Soars as Depression Trial Succeeds

Published on 16 Apr 2024 on Bloomberg

Have a confidential tip for our reporters? Intra-Cellular Therapies Inc. soared the most in more...

Read the rest of the article

Start tracking your investments with Statfolio

Intra-Cellular Therapies Inc (NASDAQ:ITCI) is set to release its Q3 2024 earnings on Oct 30, 2024...

GuruFocus.com · via Yahoo Finance 29 Oct 2024

We recently compiled a list of the 10 Most Promising Mid-Cap Stocks According to Hedge Funds. In...

Insider Monkey · via Yahoo Finance 14 Oct 2024

On September 30, 2024, JPMorgan Chase & Co, a leading global financial services firm, executed a...

GuruFocus.com · via Yahoo Finance 7 Oct 2024

We recently compiled a list of the 10 Best Mid-Cap Healthcare Stocks To Buy Now. In this article,...

Insider Monkey · via Yahoo Finance 20 Aug 2024

Intra-Cellular Therapies, Inc. ITCI reported first-quarter 2024 loss of 16 cents per share, narro...

Zacks via Yahoo Finance 9 May 2024

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) investors will be delighted, with the company turnin...

Simply Wall St. via Yahoo Finance 9 May 2024

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q1 2024 Earnings Call Transcript May 7, 2024 Intra-C...

Insider Monkey via Yahoo Finance 8 May 2024

It was a busy week in the biotech sector with lots of important regulatory and pipeline updates. ...

Zacks via Yahoo Finance 19 Apr 2024

Intra-Cellular Therapies Inc ITCI unveiled on Tuesday topline results from Study 501 evaluating l...

Benzinga 16 Apr 2024

Have a confidential tip for our reporters? Intra-Cellular Therapies Inc. soared the most in more...

Bloomberg 16 Apr 2024